Macular pigment density (MPOD (Macular Pigment Optical Density))

Macular pigment density refers to the concentration of specific carotenoids—primarily lutein, zeaxanthin, and meso-zeaxanthin—in the central region of the retina known as the macula. This layer acts as an internal filter by absorbing high-energy blue light (380–500 nm), thereby protecting retinal cells from photooxidative damage. The pigments also function as antioxidants that neutralize free radicals generated by light exposure. A higher macular pigment optical density is associated with better visual performance—including improved visual acuity, contrast sensitivity, glare recovery—and reduced risk for age-related eye diseases such as age-related macular degeneration (AMD) and potentially glaucoma. Low MPOD has been identified as a modifiable risk factor for these conditions; thus, measuring MPOD can serve both diagnostic and preventive roles in ophthalmology. The body cannot synthesize these pigments; they must be obtained from dietary sources such as leafy greens (lutein) or brightly colored vegetables like corn and peppers (zeaxanthin). Supplementation with these carotenoids can increase MPOD levels in individuals at risk. While "macular pigment density" is crucial for ocular health monitoring and disease prevention strategies, it does **not** represent a molecular therapeutic target like an enzyme or receptor—it is instead a measurable physiological parameter reflecting tissue status rather than being an actionable drug target itself.

Other names

Macular pigment optical densityMPODMacular pigmentRetinal macular carotenoid density

Not applicable for drugs; for supplements, the mechanism is through dietary intake of carotenoids that accumulate in the retina to form the protective macular pigment layer